Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers
By: David Gandara, MD
Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020
By: David R. Gandara, MD
Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers
By: David R. Gandara, MD
Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020
By: David R. Gandara, MD